Division of Medicinal Pharmacology, Institute of Natural Medicine, University of Toyama, Toyama, Japan.
Biol Pharm Bull. 2010;33(1):53-7. doi: 10.1248/bpb.33.53.
We previously reported that long-term treatment with some antidepressants at low concentrations upregulates BCL2/adenovirus E1B 19-kDa-interacting protein 3 (BNIP3) mRNA expression in NG108-15 cells without causing cell damage, suggesting that BNIP3 is a candidate of intrinsic depressive disorder-related factor(s). In this study, to clarify the physiologic functions of BNIP3, we investigated whether BNIP3 is actually related to the depressive condition in the brain using learned helplessness (LH) mice, an animal model of depression. Based on the score of escape failure, an index of depression degree, stressed animals were divided into groups with LH and without depressive-like symptoms (i.e., non-depressed phenotype, non-LH). The score of escape failure of the LH group was decreased after 14 d of treatment with imipramine in a dose-dependent manner. BNIP3 mRNA expression was enhanced in both the LH and non-LH groups. Imipramine treatment at 5 and 20 mg/kg/d enhanced BNIP3 mRNA expression only in the LH group but not in non-LH group or non-stressed group. These results raise the possibility that BNIP3 acts as an antistress factor in the brain.
我们之前曾报道,某些抗抑郁药在低浓度下长期治疗不会引起细胞损伤,但可上调 NG108-15 细胞中 BCL2/腺病毒 E1B 19-kDa 相互作用蛋白 3(BNIP3)mRNA 的表达,这表明 BNIP3 是内在抑郁相关因子的候选物之一。在这项研究中,为了阐明 BNIP3 的生理功能,我们使用习得性无助(LH)小鼠(一种抑郁动物模型)研究了 BNIP3 是否与大脑中的抑郁状态有关。根据逃避失败的评分(抑郁程度的一个指标),将应激动物分为具有 LH 和无抑郁样症状(即非抑郁表型,非 LH)的组。经过 14 天的丙咪嗪治疗,LH 组的逃避失败评分呈剂量依赖性下降。LH 和非 LH 组的 BNIP3 mRNA 表达均增强。5 和 20mg/kg/d 的丙咪嗪治疗仅增强 LH 组而非非 LH 组或非应激组的 BNIP3 mRNA 表达。这些结果表明 BNIP3 可能在大脑中充当应激抵抗因子。